#8 Newsletter – JP Jenkins
![](https://jpjenkins.com/wp-content/uploads/2024/10/Watering-can.png)
Eighth Edition This month we announced another 3 new client’s, with 2 more to go live very shortly. Sondrel, BiVictriX Therapeutics plc & 350 PPM LTD all went live over the last month! Congratulations all. We now have Bowleven plc to go live next Tuesday and another to go live the week after. First and […]
Interim Results 2024
Update on Group Transaction Proposal
Proposed divestment of shareholding in Telecredit IFN S.A
Form of Proxy for the General Meeting on 14th October 2024
Disposal of 85% shareholding in Telecredit
RGH Continues Expansion with New Sales Office in Sandwich, Kent
![](https://jpjenkins.com/wp-content/uploads/2024/10/Screenshot-2024-11-04-at-15.47.04-1024x680.png)
Date Posted: 11 August, 2024 RGH, a leading name in global recruitment and consultancy services, is thrilled to announce the opening of its new sales office in Discovery Park, Sandwich, Kent. This strategic move underscores our commitment to serving clients in the IT and Technical contract recruitment market, within the public sector frameworks and other […]
#7 Newsletter – JP Jenkins
![](https://jpjenkins.com/wp-content/uploads/2024/10/Watering-can.png)
Seventh Edition This month we announced another new client – Destiny Pharma plc and we also have Sondrel going live this Thursday! We have Bowleven plc and BiVictriX Therapeutics plc going live in September. We are delighted to announce the following new admissions to JP Jenkins: Destiny Pharma plc (JPJ:DEST), announced it’s shares have been […]
Decision of the Board to Appoint Administrators
![](https://jpjenkins.com/wp-content/uploads/2024/08/LoopUp-1-1.png)
Destiny Pharma plc(“Destiny Pharma” or “the Company”) Decision of the Board of Directors to Appoint Administrators. Brighton, United Kingdom – 22 August 2024 – Destiny Pharma, a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life threatening infections, today announces that further to the announcement of 15 July when it communicated its intention to delist and the subsequent […]
Shares now trading on JP Jenkins
![](https://jpjenkins.com/wp-content/uploads/2024/11/image.png)
21st Aug 2024 JPJ: SND ISIN: GB00BJN54579 Sondrel (Holdings) PLC (“Sondrel” or “the Company”) Shares now trading on JP Jenkins London, UK, 21st Aug 2024 – Sondrel (Holdings) PLC (JPJ: SND), Sondrel is a UK-based fabless semiconductor company specialising in high end, complex digital Application Specific Integrated Circuits (ASICs) and System on Chips (SOCs). It provides […]